multiple myeloma Archives - Express Pharma

Dr Reddy’s announce launch of Bortezomib for injection, 3.5 mg single-dose vial in US

NATCO gets US FDA approval for Pomalidomide capsules

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma

SpringWorks Therapeutics in pact with Janssen to assess Nirogacestat with Teclistamab in patients with relapsed or refractory multiple myeloma

Zydus Cadila gets US FDA approval for Doxorubicin Hydrochloride Liposome Injection

GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma

Glenmark receives Orphan Drug Designation for GBR 1342

Global multiple myeloma treatment market value to approach $9 billion by 2021: GBI Research